000289070 001__ 289070
000289070 005__ 20240604155150.0
000289070 0247_ $$2doi$$a10.1158/0008-5472.CAN-23-2957
000289070 0247_ $$2pmid$$apmid:38503267
000289070 0247_ $$2ISSN$$a0099-7013
000289070 0247_ $$2ISSN$$a0099-7374
000289070 0247_ $$2ISSN$$a0008-5472
000289070 0247_ $$2ISSN$$a1538-7445
000289070 0247_ $$2altmetric$$aaltmetric:160942800
000289070 037__ $$aDKFZ-2024-00571
000289070 041__ $$aEnglish
000289070 082__ $$a610
000289070 1001_ $$00000-0002-1572-498X$$aHerzog, Chiara$$b0
000289070 245__ $$aCigarette smoking and e-cigarette use induce shared DNA methylation changes linked to carcinogenesis.
000289070 260__ $$aPhiladelphia, Pa.$$bAACR$$c2024
000289070 3367_ $$2DRIVER$$aarticle
000289070 3367_ $$2DataCite$$aOutput Types/Journal article
000289070 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1717509073_15352
000289070 3367_ $$2BibTeX$$aARTICLE
000289070 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000289070 3367_ $$00$$2EndNote$$aJournal Article
000289070 500__ $$a2024 Jun 4;84(11):1898-1914
000289070 520__ $$aTobacco use is a major modifiable risk factor for adverse health outcomes, including cancer, and elicits profound epigenetic changes thought to be associated with long-term cancer risk. While electronic cigarettes (e-cigarettes) have been advocated as harm reduction alternatives to tobacco products, recent studies have revealed potential detrimental effects, highlighting the urgent need for further research into the molecular and health impacts of e-cigarettes. Here, we applied computational deconvolution methods to dissect the cell- and tissue-specific epigenetic effects of tobacco or e-cigarette use on DNA methylation (DNAme) in over 3,500 buccal/saliva, cervical, or blood samples, spanning epithelial and immune cells at directly and indirectly exposed sites. The 535 identified smoking-related DNAme loci (CpGs) clustered into four functional groups, including detoxification or growth signaling, based on cell type and anatomical site. Loci hypermethylated in buccal epithelial cells of smokers associated with NOTCH1/RUNX3/growth factor receptor signaling also exhibited elevated methylation in cancer tissue and progressing lung carcinoma in situ lesions, and hypermethylation of these sites predicted lung cancer development in buccal samples collected from smokers up to 22 years prior to diagnosis, suggesting a potential role in driving carcinogenesis. Alarmingly, these CpGs were also hypermethylated in e-cigarette users with a limited smoking history. This study sheds light on the cell type-specific changes to the epigenetic landscape induced by smoking-related products.
000289070 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000289070 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000289070 7001_ $$00000-0003-0648-0300$$aJones, Allison$$b1
000289070 7001_ $$00000-0002-0225-3154$$aEvans, Iona$$b2
000289070 7001_ $$0P:(DE-He78)43ea0369702f56d45fa4a32df9f49aca$$aRaut, Janhavi$$b3$$udkfz
000289070 7001_ $$00000-0001-5266-8895$$aZikan, Michal$$b4
000289070 7001_ $$00000-0001-6387-9356$$aCibula, David$$b5
000289070 7001_ $$00000-0003-2079-4779$$aWong, Andrew$$b6
000289070 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b7$$udkfz
000289070 7001_ $$00000-0003-0574-5071$$aRichmond, Rebecca C$$b8
000289070 7001_ $$00000-0002-7778-8380$$aWidschwendter, Martin$$b9
000289070 773__ $$0PERI:(DE-600)2036785-5$$a10.1158/0008-5472.CAN-23-2957$$n11$$p1898-1914$$tCancer research$$v84$$x0099-7013$$y2024
000289070 909CO $$ooai:inrepo02.dkfz.de:289070$$pVDB
000289070 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)43ea0369702f56d45fa4a32df9f49aca$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000289070 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000289070 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000289070 9141_ $$y2024
000289070 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-24
000289070 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-24
000289070 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-24
000289070 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-24
000289070 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-24
000289070 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-24
000289070 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-24
000289070 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-24
000289070 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-24
000289070 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-24
000289070 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCER RES : 2022$$d2023-10-24
000289070 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-24
000289070 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-24
000289070 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bCANCER RES : 2022$$d2023-10-24
000289070 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000289070 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x1
000289070 980__ $$ajournal
000289070 980__ $$aVDB
000289070 980__ $$aI:(DE-He78)C070-20160331
000289070 980__ $$aI:(DE-He78)HD01-20160331
000289070 980__ $$aUNRESTRICTED